Hem › Neuroblastom › Maryland
Kliniska studier för Neuroblastom i Maryland
8 studier för Neuroblastom söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- och 1 fler
RekryterarFas 3
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
4 Weeks · Alla kön · Uppdaterad 2 okt. 2026 · NCT01109394Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1
Ålder 3 till 35 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06995872Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 4 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT01005654Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekryterarFas 3
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916SPEARHEAD-3 Pediatric Study
- National Institutes of Health, Bethesda
RekryterarFas 1/2
Ålder 2 till 21 · Alla kön · Uppdaterad 11 aug. 2026 · NCT05642455A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1
Ålder 18 till 120 · Alla kön · Uppdaterad 15 juni 2026 · NCT06041516Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekryterarFas 2
Ålder 1 till 50 · Alla kön · Uppdaterad 13 mars 2026 · NCT01804634Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.